Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
about
Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary reportTreatment of prediabetesSerum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-AnalysisSex and genetic effects on upper and lower body fat and associations with diabetes in multigenerational families of African heritageIs the defect in pro-hormone processing in Type 2 diabetes mellitus restricted to the beta cell?Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional studyRelationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki Prefectural Health StudyThe effect of periodontal therapy on glycaemic control in a Hispanic population with type 2 diabetes: a randomized controlled trial.Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measuresIncidence rates and predictors of diabetes in those with prediabetes: the Strong Heart StudyImpaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey.Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.Disordered lipid metabolism and the pathogenesis of insulin resistance.Health consequences of visceral obesity.Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy.Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults.Alcohol consumption and the incidence of type II diabetesEffect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance.Relationships of generalized and regional adiposity to insulin sensitivity in men.Relationships between glycaemic abnormalities, obesity and insulin resistance in nondiabetic Polynesians of New Caledonia.Obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents.Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT).Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals.Visceral obesity: a "civilization syndrome".Obesity in minority populations: an epidemiologic assessment.β-Cell failure in type 2 diabetes: a case of asking too much of too few?A novel hierarchal-based approach to measure insulin sensitivity and secretion in at-risk populations.Relationship of body size and shape to the development of diabetes in the diabetes prevention program.Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesAdiposity, type 2 diabetes, and Alzheimer's diseaseDefects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.Oat beta-glucan ameliorates insulin resistance in mice fed on high-fat and high-fructose diet.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.Identifying candidate genes for Type 2 Diabetes Mellitus and obesity through gene expression profiling in multiple tissues or cells.What are the pharmacotherapy options for treating prediabetes?Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study.
P2860
Q24647005-14AF5F25-EA1D-476A-B0F0-88302650481CQ26783350-E71D45E0-5A62-4D16-B174-480E5D4E081EQ26824831-8F8444BD-046C-4430-A2BF-53CFF825C6B4Q28384907-70A0721E-DD34-4B2A-AB41-8754D2F4998AQ31895053-2BF82371-9421-4907-84ED-E0F16F657D83Q33273785-F8467FE8-8FFB-45BB-BBFB-930421710E43Q33566783-E7444958-95C5-46E0-BDCF-59F28A0E36B1Q33841368-B53AB24D-C472-4C28-98C9-FF369D425D96Q33953920-BC6E6354-7A4E-4B2D-9C5E-583BA7A52641Q33965429-C2C356BC-5748-4FB9-8FF1-CB4AA9AEE24DQ34099068-79CD9B91-B7D1-4314-B068-ECD995423336Q34186045-50D3B5A7-57A0-4621-88DE-336E8E62FAEFQ34335548-5F87B44C-6833-4678-8961-582115E2EC8DQ34370965-698AD9C0-93C7-4895-B3FF-878A30C3FCEEQ34454547-D3EF1572-9971-4A5F-B4F1-7D2D71041648Q34796073-F4859306-03D6-45C9-8569-81317500C0A6Q35402633-AB04AFCE-4F8C-4FB3-9B51-86E3A10DD689Q35408785-9019FE7C-D560-4FB4-9EBE-1C0368433189Q35707591-26E6AB1E-75C7-4A95-BE8B-D4F38B2C93D5Q35749987-9120510A-BAB0-4AB6-9CFF-87E25062D9AAQ35793248-0886BA11-EC6B-45CD-897C-4FEA55D11D1DQ35847063-C91649C8-1E94-4A84-96BF-ABE712811F91Q36066989-5B513FE5-7AFD-4996-B0AC-6F54DE0B8BCAQ36190631-FBE00999-9030-49CC-981C-29572ACA0A4DQ36333911-FD3FA84F-59EE-4AF5-A499-08949A140C41Q36340263-3C082D3C-63CC-4195-8902-591B904949C9Q36341476-72085AC2-9973-43F3-8069-C815CB2441C1Q36560568-B42D381E-D7AD-4FA9-93FC-4C76879AE3F8Q36608947-160D90E3-DFA5-40DC-A9B3-B80A0797E07EQ36640356-B14542FE-3AA9-49F9-826E-456419401819Q36776169-6C1F96B3-EE0A-4091-B156-A139ADFD347CQ36839510-8B59361C-EFAE-4DF7-A48F-FA49FBF879C2Q36839519-FB2043C0-B2F5-4783-B402-3C5FBF6D081EQ37250859-0AA9E547-0AD9-4AFE-BD42-4B496D080E81Q37376927-C62DA768-FE4E-4014-9F61-1EE16F5E43BEQ37411800-FAAA0412-9745-4B94-A03D-2380FDDFAD6BQ37412812-44131474-C13D-472C-9057-74063FBBC9E4Q37465872-81FA9090-7D51-4C91-91E0-C09F57F0257DQ38241464-4B999B5F-487B-4864-BCAE-ADC9AD9CAB5AQ38643179-F0CBF6BB-1D62-4E05-9754-BAF88249B1FA
P2860
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Incidence of type II diabetes ...... ty, and body-fat distribution.
@en
Incidence of type II diabetes ...... ty, and body-fat distribution.
@nl
type
label
Incidence of type II diabetes ...... ty, and body-fat distribution.
@en
Incidence of type II diabetes ...... ty, and body-fat distribution.
@nl
prefLabel
Incidence of type II diabetes ...... ty, and body-fat distribution.
@en
Incidence of type II diabetes ...... ty, and body-fat distribution.
@nl
P2093
P921
P356
P1433
P1476
Incidence of type II diabetes ...... ty, and body-fat distribution.
@en
P2093
Haffner SM
Mitchell BD
Patterson JK
P304
P356
10.2337/DIAB.39.3.283
P407
P577
1990-03-01T00:00:00Z